Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Anesthesiology ; 2024 May 16.
Artículo en Inglés | MEDLINE | ID: mdl-38753985

RESUMEN

BACKGROUND: Patient-ventilator dyssynchrony is frequently observed during assisted mechanical ventilation (MV). However, the effects of expiratory muscle contraction on patient-ventilator interaction are underexplored. We hypothesized that active expiration would affect patient-ventilator interaction and we tested our hypothesis in a mixed cohort of invasively ventilated patients with spontaneous breathing activity. METHODS: This is a retrospective observational study involving patients on assisted MV who had their esophageal (Pes) and gastric (Pgas) pressures monitored for clinical purposes. Active expiration was defined as Pgas rise (ΔPgas) ≥1.0 cmH2O during expiratory flow without a corresponding change in diaphragmatic pressure (Pdi). Waveforms of Pes, Pgas, Pdi, flow, and airway pressure (Paw) were analyzed to identify and characterize abnormal patient-ventilator interaction. RESULTS: We identified 76 patients with Pes and Pgas recordings, of whom 58 demonstrated active expiration with a median ΔPgas of 3.4 cmH2O (IQR=2.4-5.3) observed in this subgroup. Among these 58 patients, 23 presented the following events associated with expiratory muscle activity: (1) distortions in Paw and flow that resembled ineffective efforts, (2) distortions similar to autotriggering, (3) multiple triggering, (4) prolonged ventilatory cycles with biphasic inspiratory flow, with a median % (IQR) increase in mechanical inflation time and tidal volume of 54% (44-70%) and 25% (8-35%), respectively and (5) breathing exclusively by expiratory muscle relaxation. Gastric pressure monitoring was required to identify the association of active expiration with these events. Respiratory drive, assessed by the rate of inspiratory Pes decrease, was significantly higher in patients with active expiration (median [IQR] dPes/dt: 12.7 [9.0-18.5] vs 9.2 [6.8-14.2] cmH2O/sec; p<0.05). CONCLUSIONS: Active expiration can impair patient-ventilator interaction in critically ill patients. Without documenting Pgas, abnormal patient-ventilator interaction associated with expiratory muscle contraction may be mistakenly attributed to a mismatch between the patient´s inspiratory effort and mechanical inflation. This misinterpretation could potentially influence decisions regarding clinical management.

2.
J Pers Med ; 13(6)2023 Jun 12.
Artículo en Inglés | MEDLINE | ID: mdl-37373973

RESUMEN

Hiccups-like contractions, including hiccups, respiratory myoclonus, and diaphragmatic tremor, refer to involuntary, spasmodic, and inspiratory muscle contractions. They have been repeatedly described in mechanically ventilated patients, especially those with central nervous damage. Nevertheless, their effects on patient-ventilator interaction are largely unknown, and even more overlooked is their contribution to lung and diaphragm injury. We describe, for the first time, how the management of hiccup-like contractions was individualized based on esophageal and transpulmonary pressure measurements in three mechanically ventilated patients. The necessity or not of intervention was determined by the effects of these contractions on arterial blood gases, patient-ventilator synchrony, and lung stress. In addition, esophageal pressure permitted the titration of ventilator settings in a patient with hypoxemia and atelectasis secondary to hiccups and in whom sedatives failed to eliminate the contractions and muscle relaxants were contraindicated. This report highlights the importance of esophageal pressure monitoring in the clinical decision making of hiccup-like contractions in mechanically ventilated patients.

3.
J Sleep Res ; 32(1): e13656, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-35670298

RESUMEN

Growing evidence suggests that sleep could affect the immunological response after vaccination. The aim of this prospective study was to investigate possible associations between regular sleep disruption and immunity response after vaccination against coronavirus disease 2019 (COVID-19). In total, 592 healthcare workers, with no previous history of COVID-19, from eight major Greek hospitals were enrolled in this study. All subjects underwent two Pfizer-BioNTech messenger ribonucleic acid (mRNA) COVID-19 vaccine BNT162b2 inoculations with an interval of 21 days between the doses. Furthermore, a questionnaire was completed 2 days after each vaccination and clinical characteristics, demographics, sleep duration, and habits were recorded. Blood samples were collected and anti-spike immunoglobulin G antibodies were measured at 20 ± 1 days after the first dose and 21 ± 2 days after the second dose. A total of 544 subjects (30% males), with median (interquartile range [IQR]) age of 46 (38-54) years and body mass index of 24·84 (22.6-28.51) kg/m2 were eligible for the study. The median (IQR) habitual duration of sleep was 6 (6-7) h/night. In all, 283 participants (52%) had a short daytime nap. In 214 (39.3%) participants the Pittsburgh Sleep Quality Index score was >5, with a higher percentage in women (74·3%, p < 0.05). Antibody levels were associated with age (r = -0.178, p < 0.001), poor sleep quality (r = -0.094, p < 0.05), insomnia (r = -0.098, p < 0.05), and nap frequency per week (r = -0.098, p < 0.05), but after adjusting for confounders, only insomnia, gender, and age were independent determinants of antibody levels. It is important to emphasise that insomnia is associated with lower antibody levels against COVID-19 after vaccination.


Asunto(s)
COVID-19 , Coronavirus Relacionado al Síndrome Respiratorio Agudo Severo , Trastornos del Inicio y del Mantenimiento del Sueño , Masculino , Femenino , Humanos , Persona de Mediana Edad , Duración del Sueño , COVID-19/prevención & control , Vacunas contra la COVID-19 , Vacuna BNT162 , Estudios Prospectivos , Vacunación
4.
J Clin Med ; 8(6)2019 Jun 13.
Artículo en Inglés | MEDLINE | ID: mdl-31200458

RESUMEN

BACKGROUND: Intensive care unit-acquired pneumonia (ICU-AP) is a severe complication in patients admitted to the ICU. Lymphocytopenia is a marker of poor prognosis in patients with community-acquired pneumonia, but its impact on ICU-AP prognosis is unknown. We aimed to evaluate whether lymphocytopenia is an independent risk factor for mortality in non-immunocompromised patients with ICU-AP. METHODS: Prospective observational cohort study of patients from six ICUs of an 800-bed tertiary teaching hospital (2005 to 2016). RESULTS: Of the 473 patients included, 277 (59%) had ventilator-associated pneumonia (VAP). Receiver operating characteristic (ROC) analysis of the lymphocyte counts at diagnosis showed that 595 cells/mm3 was the best cut-off for discriminating two groups of patients at risk: lymphocytopenic group (lymphocyte count <595 cells/mm3, 141 patients (30%)) and non-lymphocytopenic group (lymphocyte count ≥595 cells/mm3, 332 patients (70%)). Patients with lymphocytopenia presented more comorbidities and a higher sequential organ failure assessment (SOFA) score at the moment of pneumonia diagnosis. Also, 28-day mortality and 90-day mortality were higher in patients with lymphocytopenia (28-day: 38 (27%) versus 59 (18%), 90-day: 74 (53%) versus 111 (34%)). In the multivariable model, <595 cells/mm3 resulted to be an independent predictor for 90-day mortality (Hazard Ratio 1.41; 95% Confidence Interval 1.02 to 1.94). CONCLUSION: Lymphocytopenia is an independent predictor of 90-day mortality in non-immunocompromised patients with ICU-AP.

5.
Open Forum Infect Dis ; 3(4): ofw214, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28018924

RESUMEN

We describe the clinical and imaging characteristics of 7 cases with polymerase chain reaction-confirmed novel influenza A H1N1 virus (pH1N1) infection who developed venous thromboembolic events (VTEs) while being hospitalized for influenza pneumonia. Pulmonary embolism (PE) without deep vein thrombosis (DVT) was observed in 6 of 7 cases (85.7%); PE with underlying DVT was found in 1 patient (14.3%).

6.
Stress Health ; 28(5): 381-8, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23023836

RESUMEN

Evidence suggests that gender differences appear in a variety of biological and psychological responses to stress and perhaps in coping with acute and chronic illness as well. Dysfunctional parenting is also thought to be involved in the process of coping with stress and illness; hence, the present study aimed to verify whether dysfunctional remembered parenting would influence psychological distress in a gender-specific manner in patients suffering from cancer. Patients attending an outpatient oncology clinic completed the Remembered Relationships with Parents (RRP), Hospital Anxiety and Depression and Spielberger's State-Trait Anxiety Inventory scales and the National Cancer Center Network Distress Thermometer. Although no baseline gender differences were detected, a multivariate analysis confirmed that anxiety and depression symptoms of men and women suffering from cancer are differentially affected by the RRP Control and Alienation scores. Women with remembered parental alienation and overprotection showed significantly more anxiety symptoms than men, whereas men were more vulnerable to remembered alienation than overprotection with regard to the Distress Thermometer scores. These results suggest that remembered dysfunctional parenting is crucially, and in a gender-specific manner, involved in the coping strategy adopted by male and female cancer patients.


Asunto(s)
Adaptación Psicológica , Memoria , Neoplasias/psicología , Pacientes Ambulatorios/psicología , Relaciones Padres-Hijo , Estrés Psicológico/psicología , Anciano , Anciano de 80 o más Años , Ansiedad/psicología , Depresión/psicología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Responsabilidad Parental/psicología , Caracteres Sexuales
7.
JOP ; 13(4): 342-4, 2012 Jul 10.
Artículo en Inglés | MEDLINE | ID: mdl-22797385

RESUMEN

In this paper, we will be discussing Abstracts #9061, #9062, #9065, #9072 and #9097 presented at the recent 2012 American Society of Clinical Oncology (ASCO) Annual Meeting. All of these abstracts explore innovative ways to control symptoms in cancer patients. We are hopeful that these methods are able to be used in symptomatic pancreatic cancer patients.


Asunto(s)
Neoplasias Pancreáticas/terapia , Adulto , Anciano , Investigación Biomédica , Caquexia/terapia , Fatiga/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Náusea/terapia , Cuidados Paliativos , Vómitos/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...